Cardiac Amyloidosis

Amyloidosis refers not to a single disease but to a collection of diseases in which a protein-based infiltrate deposits in tissues as beta-pleated sheets. The subtype of the disease is determined by which protein is depositing; although dozens of subtypes have been described, most are incredibly rare or of trivial importance. This analysis will focus on the main systemic forms of amyloidosis, both of which frequently involve the heart. Cardiac amyloidosis is a devastating and progressive disease. Nurses should be aware of the manifestations of cardiac amyloidosis in order to assist in early diagnosis and treatment. Early diagnosis and treatment provide patients with improved outcomes and better quality of life. Familiarity with the initial signs and symptoms and the progression of cardiac amyloidosis is necessary in order to recognize it.

    Related Conference of Cardiac Amyloidosis

    January 19-20, 2026

    27th World Congress on Nursing Care and Healthcare

    Amsterdam, Netherlands
    January 26-27, 2026

    5th World Congress on Nursing Education & Management

    Barcelona, Spain
    February 12-13, 2026

    11th World Congress on Patient Safety & Quality Healthcare

    Zurich, Switzerland
    March 17-18, 2026

    36th World Nursing and Nursing Care Congress

    Paris, France
    April 20-21, 2026

    NURSING CONGRESS 2026

    Paris, France
    April 28-29, 2026

    33rd Global Nursing and Health Care Conference

    Amsterdam, Netherlands
    April 28-29, 2026

    63rd World Nursing Conference

    London, UK
    May 04-05, 2026

    3rd Global Summit on World Nursing

    Paris, France
    August 03-04, 2026

    World Nursing Congress

    Toronto, Canada
    August 24-25, 2026

    33rd Global Nursing and Healthcare Congress

    London, UK
    October 19-20, 2026

    58th Euro Nursing & Medicare Summit

    Paris, France

    Cardiac Amyloidosis Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in